<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Trubion Scores $20M, Archus Shuts Down, AVI Biopharma’s Hope for Muscular Dystrophy, &amp; More Seattle-Area Life Sciences News</title>
	<atom:link href="http://www.xconomy.com/seattle/2009/09/03/trubion-scores-20m-archus-shuts-down-avi-biopharmas-hope-for-muscular-dystrophy-more-seattle-area-life-sciences-news/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/seattle/2009/09/03/trubion-scores-20m-archus-shuts-down-avi-biopharmas-hope-for-muscular-dystrophy-more-seattle-area-life-sciences-news/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sat, 11 Feb 2012 09:14:03 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
</channel>
</rss>

